US Bioservices & AdhereTech Collaborate to Improve Patient Adherence to Therapy 

June 4, 2019

Patients using AdhereTech Smart Pill Bottles through US Bioservices stayed on therapy longer, refilled prescriptions more frequently

Carrollton, TX – US Bioservices, a specialty pharmacy that is a part of AmerisourceBergen, announced findings from an initial program with AdhereTech. Based on the program’s successful results described below, US Bioservices plans to extend the AdhereTech offering to larger patient populations by including the Smart Pill Bottle in additional manufacturer programs.

A provider of pharma-sponsored support programs for specialty medications, AdhereTech develops patented Smart Pill Bottles for manufacturers and pharmacies across the U.S. AdhereTech collaborated with US Bioservices to analyze 18 months of fill-level data for patients using the Smart Pill Bottles for their medications. The results showed that patients new to therapy who began treatment with the Smart Pill Bottle stayed on therapy for 1.5 additional months and had 1.3 additional fills dispensed. Consistently, patients continuing on a therapy had 1.2 additional fills dispensed compared to their peers not in the program.

“US Bioservices is committed to providing our patients with the highest level of support so that they can achieve the best results from their therapies. We know that adherence remains one of the most critical challenges facing patients, and we are excited to expand access to a data-backed solution that is directly correlated to more positive outcomes,” said Angela Ward, President of US Bioservices. “This new offering is aligned with our commitment to pushing the frontier of support solutions to maximize benefits for patients, manufacturers and providers alike.”

The AdhereTech Smart Pill Bottle is simple and seamless for patients to use, requiring no additional costs or set up. The system analyzes data and sends personalized messages to patients about missed doses and upcoming refill reminders, via text message or phone call. AdhereTech’s capabilities also include notifying a patient’s pharmacy in real-time if the patient encounters a health or medication issue, enabling pharmacist intervention sooner.

As an independent specialty pharmacy, US Bioservices is dedicated to being a premier partner on programs that support patients with chronic and complex conditions. By fostering long-standing, collaborative relationships across the healthcare continuum, US Bioservices creates an integrated care environment that benefits patients, prescribers and caregivers. US Bioservices has been leveraging AdhereTech Smart Pill Bottles since 2017.

Through the breadth of resources available at AmerisourceBergen, US Bioservices develops solutions to ensure all patients on therapy receive uncompromising support to navigate their treatment, clinically, economically and socially.

###

About AmerisourceBergen                 
AmerisourceBergen provides pharmaceutical products, value-driving services and business solutions that improve access to care. Tens of thousands of healthcare providers, veterinary practices and livestock producers trust us as their partner in the pharmaceutical supply chain. Global manufacturers depend on us for services that drive commercial success for their products. Through our daily work — and powered by our 21,000 associates — we are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #10 on the Fortune 500, with more than $160 billion in annual revenue. The company is headquartered in Valley Forge, Pa. and has a presence in 50+ countries. Learn more at amerisourcebergen.com.

About AdhereTech
AdhereTech is a software and data company that develops highly-effective patient support programs, which are customized using real-time data from our patented smart devices and other feeds. Customers include many of the largest pharma companies and specialty medications, as well as most of the top specialty pharmacies in the US. AdhereTech’s programs result in patients staying on the medication longer, with increased adherence while they are on therapy. This drives additional fills of medication per patient per year, as compared to the baseline metrics. AdhereTech’s mission is to improve the patient experience by building software and devices that seamlessly connect patients to care. Learn more at www.adheretech.com.